Fortis Hiranandani Hospital, Navi Mumbai, successfully hosted a train-the-trainer live surgical workshop on 28th March 2026, focusing on advanced gynecological endoscopy training amongst young practitioners.
Wockhardt has moved closer to market approval after its antibiotic Zaynich received a positive nod from the Central Drugs Standard Control Organization, marking a breakthrough in antibiotic space.
Lupin Ltd has received tentative approval from the United States Food and Drug Administration for its generic version of Sugammadex injection
Teva Pharmaceutical is accelerating its Teva’s biosimilars expansion with three major milestones that strengthen its “Pivot to Growth” strategy and reinforce its position in the global biosimilars market.
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its generic mental health drug — Paroxetine extended-release tablets, a medication commonly used to treat mental health conditions.
Novo Nordisk is set to cut the Ozempic price in India as Indian generics flood the market following the patent expiry.
India’s pharmaceutical industry is grappling with a severe raw material crisis, putting immense pressure on API producers. Prices of key chemicals and Active Pharmaceutical Ingredients (APIs) have skyrocketed, forcing manufacturers to cut production
Apollo Hospitals today announced a structured patient transfer initiative aimed at improving access to advanced critical care through coordinated air medical transportation across India and international regions.
Alembic Pharmaceuticals Limited has secured USFDA approval for Paroxetine Extended-Release Tablets USP 12.5 mg, marking another step forward in its growing U.S. generics portfolio.
Lupin Limited has received a USFDA tentative approval for daytime sleepiness drug, strengthening its position in the US generics market.
.jpg)
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")